Figures & data
Figure 1. (a) Pityriasis rosea (chest, flank, and axilla); (b) pityriasis rosea (back).
Human Vaccines & Immunotherapeutics
Volume 17, 2021 - Issue 11
Case Report
Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine
Olivia G. Cohena Department of Dermatology, The University of Pennsylvania, Philadelphia, PA, USACorrespondence[email protected]
https://orcid.org/0000-0001-7080-5937
https://orcid.org/0000-0001-7080-5937, , & Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.